Jong K. Nam
Yangsan, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Survival Outcomes of Open Versus Robot-Assisted Radical Cystectomy: A Large-Scale Multicenter Propensity Score Matched Study.
Journal: Journal of clinical medicine
Published: April 13, 2026
Transcriptome-based Deep Learning Model for Predicting Gemcitabine and Cisplatin Chemotherapy Response in Urothelial Carcinoma: Development and External Validation.
Journal: Cancer genomics & proteomics
Published: January 14, 2026
Oncological outcomes of concurrent nephroureterectomy during radical cystectomy: A propensity score-matched analysis with multivariable adjustment from Korean multicenter database.
Journal: Surgical oncology
Published: December 17, 2025
Association of initial transurethral resection staging on survival in radical cystectomy patients.
Journal: Investigative and clinical urology
Published: November 05, 2025
Impact of carcinoma in situ of bladder at transurethral resection and radical cystectomy on survival: Retrospective multicenter study.
Journal: Investigative and clinical urology
Published: September 14, 2025
Demonstrating the non-inferiority of robotic radical cystectomy for cT3-cT4 urothelial carcinoma in the era of neoadjuvant chemotherapy: a propensity score-matched analysis.
Journal: Journal of robotic surgery
Published: July 31, 2025
The effect of neoadjuvant chemotherapy on survival outcomes subsequent to radical cystectomy in pathological T0 bladder cancer patients: A multicenter large-scale analysis.
Journal: Investigative and clinical urology
Published: April 13, 2025
Development of an Alginate Gel Composite with Antibacterial Properties Capable of Binding Calcium-Based Residual Stone Fragments in Endoscopic Stone Surgery.
Journal: Journal of endourology
Published: April 08, 2025
Publisher Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial.
Journal: Nature medicine
Published: July 02, 2024
Author Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial.
Journal: Nature medicine
Published: June 18, 2024
Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial.
Journal: Nature medicine
Published: April 05, 2024
Last Updated: 09/26/2026